title: Commentary: Anal cancer - the benefits of evidence-based treatment.
authors.affiliation: Department of Colorectal Surgery Manchester Royal Infirmary, Manchester, UK. james.hill@cmmc.nhs.uk
authors.forename: James
authors.initials: J
authors.lastname: Hill
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001005:Anus Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D018572:Disease-Free Survival; D019317:Evidence-Based Medicine; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008297:Male; D016685:Mitomycin / Q000008:administration & dosage; D009367:Neoplasm Staging; D030361:Papillomavirus Infections / Q000473:pathology; D016019:Survival Analysis
chemical_list: D016685:Mitomycin; D002945:Cisplatin; D005472:Fluorouracil